Sunshine Lake Pharma (06887.HK) files with the CSRC for the proposed implementation of full circulation of H shares

Zhitong Finance APP News, Sunshine Lake Pharma (06887.HK) announced that on September 23, 2026, the Company submitted a filing application to the China Securities Regulatory Commission regarding the conversion of 38.9217 million domestic shares of the Company held by certain shareholders of the Company into H shares of the Company (the Application), representing approximately 6.75% of the total issued share capital of the Company as at the date of this announcement (Full Circulation of H Shares).